https://crstodayeurope.com/news/cdc-updates-guidance-for-coronavirus-disease-2019/2477385/daily0.7https://crstodayeurope.com/news/second-sight-announces-departure-of-will-mcguire-president-and-ceo-and-appointment-of-gregg-williams-as-acting-ceo/2477384/daily0.7https://crstodayeurope.com/news/the-vision-council-examines-consumers-attitudes-about-covid-19-in-a-survey-for-its-members/2477382/daily0.7https://crstodayeurope.com/news/physician-views-most-european-us-physicians-far-from-satisfied-with-coronavirus-testing-strategies/2477383/daily0.7https://crstodayeurope.com/news/top-contact-lens-experts-dispel-misinformation-regarding-coronavirus/2477381/daily0.7https://crstodayeurope.com/news/arvo-annual-meeting-cancelled/2477380/daily0.7https://crstodayeurope.com/news/imprimisrx-announces-supply-agreement-with-eyecare-services-partners/2477379/daily0.7https://crstodayeurope.com/news/clearside-biomedical-appoints-dr-george-lasezkay-as-president-and-chief-executive-officer/2477375/daily0.7https://crstodayeurope.com/news/alcon-announces-european-launch-of-vivity-presbyopia-correcting-iol-with-x-wave-technology/2477377/daily0.7https://crstodayeurope.com/news/aldeyra-announces-strategic-prioritization-of-late-stage-clinical-pipeline-in-ocular-disease/2477378/daily0.7https://crstodayeurope.com/news/acuity-eye-group-offers-tips-during-national-nutrition-month-for-better-vision/2477373/daily0.7https://crstodayeurope.com/news/who-declares-covid-19-outbreak-a-pandemic/2477374/daily0.7https://crstodayeurope.com/news/reichert-technologies-signs-exclusive-deal-for-cats-reusable-tonometer-prisms/2477372/daily0.7https://crstodayeurope.com/news/nicox-updates-on-zerviate-progress-in-china-and-expands-the-countries-of-its-agreement-with-ocumension-therapeutics/2477370/daily0.7https://crstodayeurope.com/news/aad-annual-meeting-becomes-latest-casualty-of-covid-19-outbreak/2477371/daily0.7https://crstodayeurope.com/news/new-automated-method-developed-for-corneal-nerve-fiber-tortuosity-analysis/2477369/daily0.7https://crstodayeurope.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-nora-2020-annual-conference/2477365/daily0.7https://crstodayeurope.com/news/sight-sciences-announces-publication-of-first-ever-multicenter-migs-study-in-childhood-glaucoma/2477366/daily0.7https://crstodayeurope.com/news/biogen-eli-lilly-takeda-ask-staff-to-work-from-home-to-limit-coronavirus-spread/2477367/daily0.7https://crstodayeurope.com/news/orbis-international-commences-first-ever-training-program-in-the-united-states/2477368/daily0.7https://crstodayeurope.com/news/nicoxs-partner-secures-additional-approval-of-vyzulta-in-taiwan/2477363/daily0.7https://crstodayeurope.com/news/imprimisrx-announces-supply-agreement-with-ior-partners/2477364/daily0.7https://crstodayeurope.com/news/zeiss-medical-technology-announces-changes-in-ophthalmic-devices-executive-leadership/2483610/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-announces-statistically-significant-results-in-stride-3-trial-of-dry-eye-disease-drug-eysuvis/2477360/daily0.7https://crstodayeurope.com/news/envision-announces-new-collaborative-research-agreement-with-wichita-state-university/2477361/daily0.7https://crstodayeurope.com/news/analysts-give-gileads-remdesivir-50-chance-of-success-as-covid-19-treatment/2477362/daily0.7https://crstodayeurope.com/news/vision-expo-east-cancelled-due-to-coronavirus-will-consolidate-with-vision-expo-west-in-las-vegas/2477359/daily0.7https://crstodayeurope.com/news/jim-mazzo-receives-the-ellis-island-medal-of-honor/2477358/daily0.7https://crstodayeurope.com/news/long-term-visual-acuity-unaffected-by-intraocular-lens-implantation-after-congenital-cataract-surgery/2477357/daily0.7https://crstodayeurope.com/news/geuder-appoints-head-of-innovation-and-strategy/2477355/daily0.7https://crstodayeurope.com/news/alcon-launches-systane-myeyes-to-increase-continuity-of-care-and-patient-retention-following-ilux-mgd-treatment/2477353/daily0.7https://crstodayeurope.com/news/alcon-introduces-systane-hydration-preservative-free-lubricant-eye-drops-for-sensitive-dry-eyes/2477354/daily0.7https://crstodayeurope.com/news/coopervision-announces-availability-of-biofinity-toric-multifocal-contact-lenses/2477352/daily0.7https://crstodayeurope.com/news/nicoxs-end-of-phase-2-meeting-with-the-fda-sets-stage-for-ncx-470-phase-3-program-in-glaucoma/2477350/daily0.7https://crstodayeurope.com/news/allergan-receives-fda-approval-for-durysta-the-first-sustained-release-implant-for-glaucoma/2477351/daily0.7https://crstodayeurope.com/news/market-scope-new-cataract-atlas-identifies-location-of-premium-iols-and-high-volume-surgeons/2477348/daily0.7https://crstodayeurope.com/news/aao-alert-coronavirus-updates-for-ophthalmologists/2477347/daily0.7https://crstodayeurope.com/news/abbvie-allergan-clear-eu-merger-hurdle-with-gi-candidate-sale/2477346/daily0.7https://crstodayeurope.com/news/salus-university-and-national-vision-partner-to-educate-optometry-students-on-remote-eye-exam-technology/2477343/daily0.7https://crstodayeurope.com/news/imprimisrx-announces-supply-agreement-with-vision-center-network-of-america-vcna/2477342/daily0.7https://crstodayeurope.com/news/registration-open-for-eyecelerator-a-new-conference-accelerating-eye-care-advancements/2477339/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-announces-positive-topline-36-month-follow-up-data-for-second-phase-3-study-of-yutiq/2477336/daily0.7https://crstodayeurope.com/news/orbis-international-secures-500000-grant-for-flying-eye-hospital/2477337/daily0.7https://crstodayeurope.com/news/eyevance-pharmaceuticals-launches-tobradex-st-in-the-united-states/2477333/daily0.7https://crstodayeurope.com/news/the-american-optometric-association-aoa-partners-with-lyft-to-offer-free-rides-to-get-a-comprehensive-eye-exam/2477334/daily0.7https://crstodayeurope.com/news/zeiss-concludes-acquisition-of-saxonia-systems-and-creates-carl-zeiss-digital-innovation-in-dresden-germany/2477335/daily0.7https://crstodayeurope.com/news/graybug-vision-presents-preclinical-results-for-glaucoma-drug-candidate-gb-401/2477332/daily0.7https://crstodayeurope.com/news/veo-ophthalmics-to-support-the-masket-foundation-to-raise-awareness-of-aniridia/2477331/daily0.7https://crstodayeurope.com/news/iridex-launches-revised-micropulse-p3-device-for-glaucoma/2477328/daily0.7https://crstodayeurope.com/news/two-chicago-ophthalmology-practices-receive-strategic-investment-from-moonsail-capital-and-plenary-partners/2477329/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-to-provide-update-on-late-stage-clinical-development-pipeline-at-2020-research-development-day/2477322/daily0.7https://crstodayeurope.com/news/allergan-to-present-new-data-for-investigational-bimatoprost-sustained-release-at-american-glaucoma-society-annual-meeting/2477323/daily0.7https://crstodayeurope.com/news/penn-medicine-study-finds-missing-one-eye-appointment-can-lead-to-vision-loss-in-elderly/2477319/daily0.7https://crstodayeurope.com/news/allergan-sightsavers-and-the-iapb-announce-the-keep-sight-initiative-to-address-glaucoma-in-ganjam-odisha/2477318/daily0.7https://crstodayeurope.com/news/fact-mr-highlights-accelerating-sales-of-corrective-lenses-contact-lens-market-set-to-record-5-through-2029/2477317/daily0.7https://crstodayeurope.com/news/companies-in-us-drug-supply-chain-unveil-pilot-project-to-track-counterfeit-medicines/2477315/daily0.7https://crstodayeurope.com/news/eyevance-pharmaceuticals-appoints-julie-speed-as-chief-commercial-officer/2477316/daily0.7https://crstodayeurope.com/news/iscalimab-promising-for-sjogrens-syndrome/2477313/daily0.7https://crstodayeurope.com/news/verana-health-appoints-veteran-cardiologist-matthew-roe-md-as-chief-medical-officer/2477312/daily0.7https://crstodayeurope.com/news/abbvie-allergan-deal-foes-try-again-to-spur-an-ftc-crackdown/2477311/daily0.7https://crstodayeurope.com/news/humanoptics-receives-ce-mark-for-trifocal-lens-triva-aa/2477310/daily0.7https://crstodayeurope.com/news/expanding-product-needs-surgery-growth-will-drive-retinal-surgical-device-market-to-nearly-2-billion-by-2025/2477308/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-calls-on-individuals-worldwide-to-prioritize-your-eyes-in-2020/2477309/daily0.7https://crstodayeurope.com/news/myopia-management-focus-of-pipeline-expansion-for-leo-lens-pharma/2477307/daily0.7https://crstodayeurope.com/news/schwind-hosts-18th-international-user-meeting-in-hamburg/2477306/daily0.7https://crstodayeurope.com/news/santen-visionary-study-demonstrates-effectiveness-and-tolerability-of-tafluprost-timolol-combination-therapy-in-open-angle-glaucoma/2477305/daily0.7https://crstodayeurope.com/news/palatin-technologies-announces-first-patient-enrolled-in-dry-eye-disease-phase-2-clinical-trial-with-pl9643/2477303/daily0.7https://crstodayeurope.com/news/fifteenth-annual-eyes-on-capitol-hill-advocacy-event/2477302/daily0.7https://crstodayeurope.com/news/santen-forges-ophthalmology-partnerships-with-verily-and-who/2477300/daily0.7https://crstodayeurope.com/news/artificial-iris-from-humanoptics-now-reimburseable-medical-product/2477301/daily0.7https://crstodayeurope.com/news/alcon-receives-fda-approval-for-otc-pataday-once-daily-relief-for-allergy-relief/2477298/daily0.7https://crstodayeurope.com/news/certain-chronic-illnesses-tied-to-increased-crash-risk-for-elderly-drivers/2477296/daily0.7https://crstodayeurope.com/news/microstent-reduces-post-cataract-surgery-intraocular-pressure-in-glaucoma-patients/2477293/daily0.7https://crstodayeurope.com/news/seco-20-20-unveils-exclusive-lineup-of-special-sessions/2477292/daily0.7https://crstodayeurope.com/news/market-scope-miami-philadelphia-and-virginia-beach-in-top-10-markets-of-glaucoma-treatment-opportunity/2477291/daily0.7https://crstodayeurope.com/news/aerpio-pharmaceuticals-presents-new-data-showing-potential-of-topical-ocular-formulation-of-akb-9778-when-combined-with-prostaglandin/2477289/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-presents-data-demonstrating-a-reduction-in-iop-in-patients-treated-with-otx-tic/2477290/daily0.7https://crstodayeurope.com/news/santen-and-verily-establish-joint-venture-to-develop-and-commercialize-unique-ophthalmic-devices/2477285/daily0.7https://crstodayeurope.com/news/calvin-roberts-md-named-president-and-ceo-of-lighthouse-guild/2477286/daily0.7https://crstodayeurope.com/news/nicox-to-present-ncx-470-phase-2-results-at-glaucoma-360-new-horizons-forum/2477281/daily0.7https://crstodayeurope.com/news/marinosolv-technology-successfully-used-in-preclinical-study-of-neurotrophic-keratopathy/2477279/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-strategic-cooperation-agreement-with-senshinkai-eye-institute-in-japan/2477276/daily0.7https://crstodayeurope.com/news/verana-health-acquires-pya-analytics-announces-100-million-financing/2477275/daily0.7https://crstodayeurope.com/news/trefoil-therapeutics-selects-agc-biologics-as-lead-manufacturer-of-tthx1114-for-treatment-of-corneal-diseases/2477274/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-the-evo-implantable-lens-us-clinical-trial-is-underway/2477273/daily0.7https://crstodayeurope.com/news/nicox-receives-formulation-patent-extending-ncx-470-us-patent-coverage-to-2039/2477270/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-appointment-of-michelle-senchyna-phd-as-vice-president-clinical-development-and-medical-affairs/2477271/daily0.7https://crstodayeurope.com/news/acucela-meets-with-nasa-and-trish-for-phase-1-update-for-ss-oct-project/2477272/daily0.7https://crstodayeurope.com/news/eyetech-launches-eyeon-ultra-compact-eye-tracking-tablet-platform/2477269/daily0.7https://crstodayeurope.com/news/several-best-us-hospitals-penalized-over-too-high-rates-of-infection-injury/2483609/daily0.7https://crstodayeurope.com/news/study-validates-righteyes-eye-tracking-for-detecting-vision-biomarkers-associated-with-different-severities-of-concussion/2483608/daily0.7https://crstodayeurope.com/news/midwest-vision-partners-announces-partnership-with-specialty-eye-institute/2477268/daily0.7https://crstodayeurope.com/news/refocus-eye-health-acquires-soll-eye/2477266/daily0.7https://crstodayeurope.com/news/bausch-lomb-and-terracycle-partner-to-launch-canadas-first-and-only-contact-lens-recycling-program/2477265/daily0.7https://crstodayeurope.com/news/bausch-health-and-clearside-biomedical-announce-publication-of-pivotal-phase-3-data-on-xipere/2477264/daily0.7https://crstodayeurope.com/news/glauconix-biosciences-promotes-kimberly-southern-to-chief-executive-officer/2477262/daily0.7https://crstodayeurope.com/news/americans-want-more-from-eye-care-but-fear-costs-finds-new-study/2477261/daily0.7https://crstodayeurope.com/news/think-about-your-eyes-launches-enhanced-website/2477258/daily0.7https://crstodayeurope.com/news/potent-affroneye-saffron-extract-may-lower-risk-of-glaucoma/2477259/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-and-ocumension-therapeutics-sign-license-agreement-to-develop-and-commercialize-dexycu-in-china-hong-kong-macau-and-taiwan/2477260/daily0.7https://crstodayeurope.com/news/optimal-atropine-concentration-for-two-year-myopia-control-affirmed/2477255/daily0.7https://crstodayeurope.com/news/the-new-england-journal-of-medicine-publishes-comprehensive-data-from-phase-3-clinical-trial-of-tepezza-for-thyroid-eye-disease/2477252/daily0.7https://crstodayeurope.com/news/tangible-science-announces-timing-for-tangible-boost-launch/2477250/daily0.7https://crstodayeurope.com/news/clearwave-launches-new-patient-interface-solution/2477249/daily0.7https://crstodayeurope.com/news/fda-approves-first-treatment-for-thyroid-eye-disease/2477247/daily0.7https://crstodayeurope.com/news/alexander-van-der-mey-named-new-cco-at-optimo-medical-ag/2477248/daily0.7https://crstodayeurope.com/news/covenant-surgical-partners-rebrands-company-announces-partnership-with-texas-eye-care-network/2477246/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-announces-first-patient-enrolled-in-the-phase-3-invigorate-trial-in-allergic-conjunctivitis/2477243/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-fda-approval-of-its-athlone-ireland-facility-for-production-of-rocklatan/2477245/daily0.7https://crstodayeurope.com/news/fda-accepting-less-data-more-surrogate-endpoints-in-trials/2477241/daily0.7https://crstodayeurope.com/news/study-finds-fewer-than-half-of-us-clinical-trials-complied-with-new-regulations-on-reporting-results/2477242/daily0.7https://crstodayeurope.com/news/lifecell-receives-accreditation-from-american-association-of-tissue-banks-aatb/2477240/daily0.7https://crstodayeurope.com/news/hoya-surgical-optics-launches-joint-venture-with-gemax-in-china/2477238/daily0.7https://crstodayeurope.com/news/mojo-vision-developing-smart-contact-lens/2477237/daily0.7https://crstodayeurope.com/news/bausch-lomb-secures-additional-approvals-of-vyzulta-in-hong-kong-and-argentina/2477234/daily0.7https://crstodayeurope.com/news/neuroptika-announces-enrollment-of-first-patient-in-phase-2-clinical-trial-for-dry-eye-disease/2477235/daily0.7https://crstodayeurope.com/news/allergan-teams-up-with-super-bowl-mvp-von-miller-to-raise-awareness-of-glaucomas-impact-on-daily-living/2477236/daily0.7https://crstodayeurope.com/news/analysis-fdas-efforts-to-speed-drug-approval-may-have-led-to-less-rigorous-clinical-outcome-requirements/2477231/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-announces-completion-of-enrollment-of-stride-3-trial-for-eysuvis-for-dry-eye-disease/2477232/daily0.7https://crstodayeurope.com/news/irisvision-and-samsung-announce-partnership-to-roll-out-vision-correction-software-platform/2477229/daily0.7https://crstodayeurope.com/news/maculogix-introduces-the-adaptdx-pro-guided-by-theia/2477230/daily0.7https://crstodayeurope.com/news/oyster-point-pharmas-oc-01-nasal-spray-meets-primary-endpoint-in-phase-2-mystic-trial-in-subjects-with-dry-eye-disease/2477225/daily0.7https://crstodayeurope.com/news/staar-surgical-gains-supplemental-lens-approval-for-evo-visian-icl-to-target-post-cataract-market-opportunity/2477226/daily0.7https://crstodayeurope.com/news/the-american-optometric-association-aoa-launches-nationwide-campaign-to-make-2020-the-year-of-the-eye-exam/2477227/daily0.7https://crstodayeurope.com/news/aao-survey-reveals-most-americans-know-a-lot-less-about-eye-health-than-they-think-they-do/2477222/daily0.7https://crstodayeurope.com/news/bausch-lomb-secures-approval-of-vyzulta-in-mexico/2477224/daily0.7https://crstodayeurope.com/news/watchdog-nhs-delays-responsible-for-glaucoma-patients-going-blind/2477221/daily0.7https://crstodayeurope.com/news/improved-reimbursement-for-endoscopic-cyclophotocoagulation-ecp-when-combined-with-cataract-surgery/2477219/daily0.7https://crstodayeurope.com/news/ideaya-biosciences-and-boston-childrens-hospital-collaborate-on-preclinical-evaluation-of-ide196-for-sturge-weber-syndrome/2477220/daily0.7https://crstodayeurope.com/news/us-cancer-death-rates-are-dropping-at-the-fastest-pace-on-record/2477215/daily0.7https://crstodayeurope.com/news/abbvie-announces-leadership-team-and-creation-of-new-business-allergan-aesthetics-upon-completion-of-acquisition/2477216/daily0.7https://crstodayeurope.com/news/new-chair-members-named-to-eversight-board-of-directors/2477217/daily0.7https://crstodayeurope.com/news/tarsus-pharmaceuticals-raises-60-million-for-demodex-blepharitis-drug-trial/2477213/daily0.7https://crstodayeurope.com/news/aerpio-pharmaceuticals-akb-9778-produced-iop-lowering-with-minimal-hyperemia-when-combined-with-prostaglandin/2477211/daily0.7https://crstodayeurope.com/news/aura-biosciences-appoints-george-golumbeski-phd-as-chairman-of-the-board-of-directors/2477212/daily0.7https://crstodayeurope.com/news/the-firmament-group-invests-in-three-ophthalmology-practices-and-an-asc-in-st-louis/2477206/daily0.7https://crstodayeurope.com/news/irisvision-and-samsung-announce-partnership-to-bring-clinically-validated-vision-technologies-to-over-200-million-low-vision-patients-globally/2477207/daily0.7https://crstodayeurope.com/news/protokinetix-aagp-dry-eye-therapy-testing-results/2477203/daily0.7https://crstodayeurope.com/news/new-analysis-expands-on-link-between-pharma-payments-prescribing/2477201/daily0.7https://crstodayeurope.com/news/aoa-changes-on-the-horizon-for-evaluation-and-management-services/2477202/daily0.7https://crstodayeurope.com/news/laundry-pods-cause-growing-number-of-eye-injuries-in-u-s/2477198/daily0.7https://crstodayeurope.com/news/enchroma-introduces-line-of-lenses-for-low-vision-and-age-related-eye-conditions/2477199/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-acceptance-for-review-of-the-roclanda-marketing-authorization-application-in-europe/2477200/daily0.7https://crstodayeurope.com/news/2019-year-in-focus/2477197/daily0.7https://crstodayeurope.com/news/market-scope-ophthalmic-deals-surge-in-2018-2019-most-transactions-involve-new-ventures/2477195/daily0.7https://crstodayeurope.com/news/10-best-foods-to-protect-your-eyesight/2477196/daily0.7https://crstodayeurope.com/news/coopervision-launches-first-best-practices-scholarship-program/2477193/daily0.7https://crstodayeurope.com/news/occupational-radiation-exposure-tied-to-higher-cataract-risk/2477191/daily0.7https://crstodayeurope.com/news/5736-of-the-worlds-poorest-people-received-the-gift-of-sight-in-2019-at-the-tej-kohli-cornea-institute/2477189/daily0.7https://crstodayeurope.com/news/allergan-foundation-giving-reaches-95-million-since-inception/2477188/daily0.7https://crstodayeurope.com/news/nicoxs-ncx-4251-meets-primary-endpoint-in-phase-2-blepharitis-trial-and-shows-promising-efficacy-in-dry-eye-disease/2477187/daily0.7https://crstodayeurope.com/news/bausch-health-licenses-novaliqs-nov03-investigational-treatment-for-dry-eye-disease-associated-with-meibomian-gland-dysfunction/2477185/daily0.7https://crstodayeurope.com/news/midwest-vision-partners-announces-partnership-with-cleveland-eye-clinic/2477186/daily0.7https://crstodayeurope.com/news/ultraviolet-light-exposure-identified-as-factor-linked-to-eye-disease-fuchs-endothelial-corneal-dystrophy/2477181/daily0.7https://crstodayeurope.com/news/trump-administration-advances-plan-to-allow-certain-prescription-drug-imports-from-canada/2477183/daily0.7https://crstodayeurope.com/news/the-american-optometric-association-urges-employers-to-pledge-to-make-2020-the-year-of-the-eye-exam/2477180/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-strategic-alliance-agreement-with-california-center-for-refractive-surgery-ccrs/2477178/daily0.7https://crstodayeurope.com/news/blue-light-glasses-helpful-or-just-hype/2477179/daily0.7https://crstodayeurope.com/news/with-eyecare-partners-deal-swiss-firm-sees-a-base-for-organic-growth-expansion-and-consolidation-of-u-s-vision-market/2477176/daily0.7https://crstodayeurope.com/news/1-800-contacts-enters-agreement-to-acquire-vision-start-up-6over6-vision/2477177/daily0.7https://crstodayeurope.com/news/bausch-lomb-initiates-clinical-trial-evaluating-new-cohesive-ophthalmic-viscosurgical-device-ovd/2477174/daily0.7https://crstodayeurope.com/news/ffl-partners-to-sell-eyecare-partners/2477173/daily0.7https://crstodayeurope.com/news/fda-advisory-committee-votes-unanimously-to-support-the-use-of-teprotumumab-for-the-treatment-of-thyroid-eye-disease-ted/2477171/daily0.7https://crstodayeurope.com/news/eyesight-philanthropist-james-chen-awarded-honorary-degree-by-university-of-bath/2477169/daily0.7https://crstodayeurope.com/news/horizon-therapeutics-trading-halted-today-fda-committee-meeting-to-discuss-teprotumumab-for-thyroid-eye-disease/2477167/daily0.7https://crstodayeurope.com/news/stephen-hahn-confirmed-as-new-fda-chief/2477168/daily0.7https://crstodayeurope.com/news/seed-acquires-majority-stake-in-sensimed/2477166/daily0.7https://crstodayeurope.com/news/focalpoint-holdings-partners-with-greensky-patient-solutions-to-enable-8000-ophthalmology-providers-to-provide-patient-financing/2477162/daily0.7https://crstodayeurope.com/news/gensight-biologics-reports-findings-from-studies-highlighting-benefits-from-lumevoq-compared-to-lhon-natural-history/2477163/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-fda-ide-clinical-study-approval-2/2477164/daily0.7https://crstodayeurope.com/news/watching-for-radiation-harm-after-interventional-procedures/2477165/daily0.7https://crstodayeurope.com/news/bausch-lomb-introduces-envista-toric-mx60et-iol-with-stableflex-technology/2477160/daily0.7https://crstodayeurope.com/news/joel-leftwich-named-executive-director-of-william-l-hudson-bvi-workforce-innovation-orkforce-innovation-center/2477155/daily0.7https://crstodayeurope.com/news/tom-frinzi-to-retire-from-johnson-replaced-by-warren-foust/2477156/daily0.7https://crstodayeurope.com/news/leiters-and-prodigy-health-enter-into-national-sales-and-marketing-agreement/2477157/daily0.7https://crstodayeurope.com/news/imprimisrxs-fda-registered-outsourcing-facility-issued-california-license/2477158/daily0.7https://crstodayeurope.com/news/aao-and-ascrs-launch-ophthovation-joint-venture-business-innovation-conferences/2477151/daily0.7https://crstodayeurope.com/news/vision-innovation-partners-completes-acquisitions-in-northern-maryland/2477150/daily0.7https://crstodayeurope.com/news/sight-sciences-appoints-erica-rogers-to-its-board-of-directors/2477149/daily0.7https://crstodayeurope.com/news/korean-ophthalmologist-oh-jungwoo-performs-25-sec-lasek-in-public-for-the-first-time/2477147/daily0.7https://crstodayeurope.com/news/bvi-expands-vitreoretinal-surgery-presence/2477146/daily0.7https://crstodayeurope.com/news/smartphone-app-spots-undiagnosed-symptomatic-dry-eye-helps-identify-risk-factors/2477144/daily0.7https://crstodayeurope.com/news/quick-eye-test-may-flag-unrecognized-brain-injury/2477145/daily0.7https://crstodayeurope.com/news/nicox-signs-agreement-for-zerviate-in-south-korea/2477143/daily0.7https://crstodayeurope.com/news/new-consensus-recommendations-guide-sjogrens-syndrome-management/2477140/daily0.7https://crstodayeurope.com/news/novartis-harnessing-ai-in-amazon-partnership-aimed-at-revamping-drug-manufacturing-supply/2477142/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-submits-marketing-authorization-application-for-roclanda-in-europe/2477139/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-announces-positive-topline-results-from-part-1-of-adaptive-phase-3-renew-trial-in-dry-eye-disease/2477138/daily0.7https://crstodayeurope.com/news/senate-panel-advances-trumps-nominee-for-fda-commissioner/2477137/daily0.7https://crstodayeurope.com/news/new-funding-for-orbis-international-will-increase-global-access-to-eye-care-through-technology/2477136/daily0.7https://crstodayeurope.com/news/study-shows-superior-success-rate-for-extra-elt-compared-with-trabectome-in-patients-with-glaucoma-plus-cataract-surgery/2477135/daily0.7https://crstodayeurope.com/news/righteye-vision-system-receives-breakthrough-device-designation-from-the-fda-for-parkinsons-disease-test/2477133/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-introduces-tecnis-toric-ii-1-piece-iol-as-new-monofocal-option-for-patients-with-astigmatism/2477134/daily0.7https://crstodayeurope.com/news/novabay-pharmaceuticals-launches-novawipes-eyelid-wipes-on-amazon-com/2477129/daily0.7https://crstodayeurope.com/news/acuity-eyecare-group-announces-rebranding-and-new-corporate-name/2477131/daily0.7https://crstodayeurope.com/news/nora-and-pink-concussions-offer-new-educational-resource-on-women-and-concussions/2477132/daily0.7https://crstodayeurope.com/news/zeiss-acquires-saxonia-systems-software-company/2477128/daily0.7https://crstodayeurope.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/daily0.7https://crstodayeurope.com/news/vance-thompson-vision-acquires-nebraska-laser-eye-institute/2477125/daily0.7https://crstodayeurope.com/news/air-pollution-linked-to-higher-glaucoma-risk/2477124/daily0.7https://crstodayeurope.com/news/gn-corporation-vision-restored-with-corneal-cell-transplant-using-a-nano-sheet-technique/2477121/daily0.7https://crstodayeurope.com/news/iveric-bio-appoints-guangping-gao-phd-internationally-recognized-gene-therapy-pioneer-as-chief-strategist-gene-therapy/2477122/daily0.7https://crstodayeurope.com/news/teva-drugmakers-in-talks-with-u-s-to-end-generics-probes/2477123/daily0.7https://crstodayeurope.com/news/alcon-to-hold-second-annual-alcon-retina-fellows-institute/2477120/daily0.7https://crstodayeurope.com/news/coopervision-earns-global-impact-award-for-rebate-donation-program-resulting-in-800000-raised-for-optometry-giving-sight/2477119/daily0.7https://crstodayeurope.com/news/novartis-to-acquire-the-medicines-company-for-9-7-billion/2477118/daily0.7https://crstodayeurope.com/news/ophthalmic-laser-market-expected-to-total-406-million-in-2019/2477117/daily0.7https://crstodayeurope.com/news/horizon-therapeutics-launches-new-online-community-connecting-people-living-with-thyroid-eye-disease/2477116/daily0.7https://crstodayeurope.com/news/clearwave-announces-interface-with-modernizing-medicine/2477113/daily0.7https://crstodayeurope.com/news/santen-receives-canadian-drug-expert-committee-reimbursement-recommendation-for-verkazia-eye-drops/2477114/daily0.7https://crstodayeurope.com/news/protokinetix-aagp-dry-eye-therapy-program-launched/2477115/daily0.7https://crstodayeurope.com/news/enchroma-makes-new-indoor-color-blind-glasses-available-to-the-public/2477109/daily0.7https://crstodayeurope.com/news/glaukos-completes-acquisition-of-avedro/2477110/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-receives-european-commission-approval-for-glaucoma-drug-rhokiinsa/2477111/daily0.7https://crstodayeurope.com/news/lightmed-introduces-new-design-of-lightlas-truscan-pro-photocoagulator/2477108/daily0.7https://crstodayeurope.com/news/report-novartis-weighing-takeover-offer-for-the-medicines-company/2477107/daily0.7https://crstodayeurope.com/news/warby-parker-is-launching-scout-its-own-line-of-contact-lenses/2477105/daily0.7https://crstodayeurope.com/news/tarsius-pharma-announces-granting-of-orphan-drug-designation-for-trs-by-the-european-medicines-agency/2477104/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-announces-availability-of-acuvue-oasys-with-transitions-light-intelligent-technology-in-the-uk/2477102/daily0.7https://crstodayeurope.com/news/baring-private-equity-asia-agrees-to-acquire-lumenis/2477103/daily0.7https://crstodayeurope.com/news/nidek-launches-the-yc-200-and-yc-200-s-plus-in-the-united-states/2477101/daily0.7https://crstodayeurope.com/news/novabay-pharmaceuticals-launches-novasight-daily-vitamin-for-ocular-health-on-amazon-com/2477099/daily0.7https://crstodayeurope.com/news/first-contact-lens-for-childhood-myopia-coming-to-the-united-states-in-2020/2477098/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-agreement-to-acquire-avizorex-pharma-to-advance-its-dry-eye-program/2477097/daily0.7https://crstodayeurope.com/news/new-test-aims-to-make-eye-testing-more-accessible/2477096/daily0.7https://crstodayeurope.com/news/vision-health-initiative-named-a-mutual-of-america-2019-community-partnership-award-winner/2477094/daily0.7https://crstodayeurope.com/news/extreme-dry-eye-left-fox-news-shannon-bream-suicidal-until-she-found-hope-in-treatment/2477095/daily0.7https://crstodayeurope.com/news/katena-announces-the-acquisition-of-micro-medical-instruments/2477093/daily0.7https://crstodayeurope.com/news/understanding-the-eyes-plumbing-could-lead-to-future-treatments-for-glaucoma-other-diseases/2477092/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-appoints-george-o-elston-as-chief-financial-officer-and-head-of-corporate-development/2477091/daily0.7https://crstodayeurope.com/news/armenian-eyecare-project-surpasses-milestone-of-10000-patients-screened-using-artificial-intelligence-eye-screening-technology/2477088/daily0.7https://crstodayeurope.com/news/solving-a-medical-mystery-crucial-to-future-space-travel/2477089/daily0.7https://crstodayeurope.com/news/bausch-lomb-and-terracycle-announce-donation-of-new-custom-training-modules-to-guide-dog-foundation/2477087/daily0.7https://crstodayeurope.com/news/elt-sight-acquires-assets-and-ip-of-mlase-ag-excimer-ophthalmic-laser-system-for-glaucoma-surgery/2477086/daily0.7https://crstodayeurope.com/news/eversight-awarded-50000-to-investigate-cell-expansion-to-address-global-cornea-shortage/2477085/daily0.7https://crstodayeurope.com/news/bloomberg-allergan-ceos-best-career-decision-was-taking-a-huge-pay-cut/2477083/daily0.7https://crstodayeurope.com/news/eyecloud-moist-heat-therapy-now-directly-available-to-dry-eye-patients/2477084/daily0.7https://crstodayeurope.com/news/envision-announces-dates-calls-for-submissions-for-2020-conferences/2477082/daily0.7https://crstodayeurope.com/news/novaliq-and-jiangsu-hengrui-medicine-announce-a-strategic-collaboration-in-ophthalmology-for-the-eyesol-based-investigational-products-nov03-and-cyclasol-in-china/2477080/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-announces-strategic-update-and-operational-restructuring/2477081/daily0.7https://crstodayeurope.com/news/teprotumumab-improves-bulging-qol-in-thyroid-eye-disease/2477078/daily0.7https://crstodayeurope.com/news/leica-microsystems-and-precision-lens-sign-agreement-to-expand-leica-ophthalmic-portfolio-in-the-u-s-midwest/2477077/daily0.7https://crstodayeurope.com/news/optina-diagnostics-and-wagner-macula-retina-center-will-collaborate-to-conduct-a-clinical-study-to-identify-the-causes-of-memory-loss-through-eye-diagnostics/2477076/daily0.7https://crstodayeurope.com/news/ocuphire-pharma-announces-results-from-two-phase-2-clinical-studies-of-nyxol-eye-drops/2477075/daily0.7https://crstodayeurope.com/news/pioneering-ophthalmologist-spencer-p-thornton-md-dies-at-age-90/2477074/daily0.7https://crstodayeurope.com/news/vision-plan-customer-satisfaction-increases-j-d-power-finds/2477073/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-positive-topline-results-for-netarsudil-in-phase-2-study-conducted-in-japan/2477069/daily0.7https://crstodayeurope.com/news/new-ecp-and-parent-survey-shows-the-significant-need-for-myopia-education/2477070/daily0.7https://crstodayeurope.com/news/trump-to-nominate-stephen-hahn-cancer-researcher-to-head-fda/2477068/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-announces-addition-of-dexycu-and-yutiq-to-department-of-veteran-affairs-federal-supply-schedule/2477065/daily0.7https://crstodayeurope.com/news/american-academy-of-optometry-foundation-announces-the-2019-vincent-salierno-scholarship-recipients/2477066/daily0.7https://crstodayeurope.com/news/omeros-announces-publication-of-study-results-on-the-impact-of-omidria-on-opioid-use-and-pain/2477067/daily0.7https://crstodayeurope.com/news/oyster-point-pharma-announces-pricing-of-initial-public-offering/2477064/daily0.7https://crstodayeurope.com/news/ema-and-fda-accept-marketing-applications-for-chugais-satralizumab-in-neuromyelitis-optica-spectrum-disorder-nmosd/2477062/daily0.7https://crstodayeurope.com/news/integrated-clinical-trial-analyses-further-substantiate-that-teprotumumab-significantly-improves-debilitating-effects-of-thyroid-eye-disease/2477063/daily0.7https://crstodayeurope.com/news/allergan-issues-recall-for-certain-lots-of-xen-45/2477061/daily0.7https://crstodayeurope.com/news/aldeyra-therapeutics-releases-expanded-results-from-allergen-chamber-trial-and-announces-plans-to-initiate-the-phase-3-invigorate-trial-in-patients-with-allergic-conjunctivitis/2477060/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-launches-tecnis-eyhance-monofocal-iol-in-india/2477059/daily0.7https://crstodayeurope.com/news/eyeprint-prosthetics-releases-new-scleral-lens-technology-scanfitpro/2477058/daily0.7https://crstodayeurope.com/news/manufacturers-providers-increasingly-rely-on-premium-cataract-surgery-revenue/2477057/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-ceases-customer-facing-operations-for-sightbox-online-contact-lens-subscription-service/2477054/daily0.7https://crstodayeurope.com/news/fda-accepts-genentechs-biologics-license-application-for-satralizumab-for-neuromyelitis-optica-spectrum-disorder/2477055/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-the-appointment-of-david-a-hollander-md-mba-as-chief-research-development-officer/2477056/daily0.7https://crstodayeurope.com/news/eyenovia-advances-microline-for-the-treatment-of-presbyopia-reprioritizes-late-stage-ophthalmology-pipeline/2477052/daily0.7https://crstodayeurope.com/news/iveric-bio-appoints-abraham-scaria-phd-as-chief-scientific-officer/2477050/daily0.7https://crstodayeurope.com/news/study-eye-damage-linked-to-over-the-counter-vitamin-that-lowers-cholesterol-can-be-reversed/2477051/daily0.7https://crstodayeurope.com/news/novabay-pharmaceuticals-to-distribute-the-nulids-system-for-the-treatment-of-dry-eye-in-certain-u-s-geographies/2477048/daily0.7https://crstodayeurope.com/news/visual-dysfunction-an-underrecognized-symptom-of-parkinsons/2477049/daily0.7https://crstodayeurope.com/news/secondhand-smoke-may-damage-childrens-eyes/2477043/daily0.7https://crstodayeurope.com/news/sightglass-vision-to-present-new-data-on-its-novel-lenses-to-control-nearsightedness-in-children-at-3rd-world-congress-of-optometry/2477040/daily0.7https://crstodayeurope.com/news/oculus-teams-up-with-bhvi-to-improve-myopia-management/2477036/daily0.7https://crstodayeurope.com/news/new-combined-data-from-the-phase-2-and-phase-3-teprotumumab-clinical-trials-to-be-presented-during-the-american-thyroid-association-annual-meeting/2477038/daily0.7https://crstodayeurope.com/news/julia-a-haller-md-elected-to-national-academy-of-medicine/2477033/daily0.7https://crstodayeurope.com/news/bausch-health-licenses-clearside-biomedicals-xipere-an-investigational-treatment-for-macular-edema-associated-with-uveitis/2477035/daily0.7https://crstodayeurope.com/news/sight-sciences-international-migs-study-confirms-long-term-safety-and-efficacy-of-the-omni-surgical-system-predicate-device-visco360/2477032/daily0.7https://crstodayeurope.com/news/idx-taps-former-labcorp-executive-to-lead-sales-and-customer-success/2477030/daily0.7https://crstodayeurope.com/news/new-hope-for-patients-with-vision-loss-at-savir-center-for-vision-restoration/2477031/daily0.7https://crstodayeurope.com/news/nicox-reports-positive-results-of-secondary-analyses-from-phase-2-trial-further-highlighting-potential-of-ncx-470-in-glaucoma/2477029/daily0.7https://crstodayeurope.com/news/coopervision-shares-latest-contact-lens-research-results-in-paper-and-poster-presentations-at-academy-2019/2477027/daily0.7https://crstodayeurope.com/news/righteye-helps-fight-neurological-disorders-traumatic-brain-injury-and-learning-disabilities-with-database-of-one-billion-eye-tracking-data-points/2477028/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-to-showcase-new-data-and-interactive-experiences-at-2019-american-academy-of-optometry-annual-meeting/2477026/daily0.7https://crstodayeurope.com/news/wolfgang-haigis-scientist-known-for-his-formulae-dies-at-72/2477025/daily0.7https://crstodayeurope.com/news/alcon-contact-lens-and-cataract-innovations-to-headline-clinical-and-educational-program-at-academy19/2477022/daily0.7https://crstodayeurope.com/news/aerpio-pharmaceuticals-announces-review-of-strategic-alternatives/2477023/daily0.7https://crstodayeurope.com/news/fixing-cataracts-significantly-improves-driving-performance-in-seniors/2477021/daily0.7https://crstodayeurope.com/news/objectiveed-joins-microsofts-ai-for-accessibility-program-to-develop-braille-ai-tutor-platform/2477020/daily0.7https://crstodayeurope.com/news/proqr-receives-rare-pediatric-disease-designation-from-fda-for-sepofarsen-for-the-treatment-of-lca10/2477018/daily0.7https://crstodayeurope.com/news/largest-study-of-chinese-americans-uncovers-unique-risk-factors-for-visual-impairment/2477019/daily0.7https://crstodayeurope.com/news/aura-biosciences-announces-updated-phase-1b-2-clinical-data-for-au-011-presented-at-aao/2477015/daily0.7https://crstodayeurope.com/news/sleep-apnea-linked-to-blinding-eye-disease-in-people-with-diabetes/2477016/daily0.7https://crstodayeurope.com/news/regenerx-jv-partner-updates-on-strategic-dry-eye-discussions/2477013/daily0.7https://crstodayeurope.com/news/world-health-organization-to-address-its-first-world-vision-report-at-academy-2019-orlando/2477014/daily0.7https://crstodayeurope.com/news/alcon-announces-findings-from-iris-registry-analyses-on-real-world-cataract-patients-at-aao/2477012/daily0.7https://crstodayeurope.com/news/eyevance-pharmaceuticals-acquires-tobradex-st-and-natacyn/2477011/daily0.7https://crstodayeurope.com/news/allergan-shareholders-approve-proposed-acquisition-by-abbvie/2477010/daily0.7https://crstodayeurope.com/news/luneau-technology-acquires-next-sight-to-enter-telehealth-market/2477007/daily0.7https://crstodayeurope.com/news/sun-pharma-launches-cequa-for-the-treatment-of-dry-eye-disease-in-the-us/2477008/daily0.7https://crstodayeurope.com/news/new-approach-to-slowing-nearsightedness-in-children-shows-promise/2477006/daily0.7https://crstodayeurope.com/news/envision-dallas-lighthouse-for-the-blind-to-house-american-foundation-for-the-blind-center-on-vision-loss-esthers-place/2477004/daily0.7https://crstodayeurope.com/news/antibody-based-eye-drops-show-promise-for-treating-dry-eye-disease/2477005/daily0.7